Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | ABL1 | P00519 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | AKT2 | P31751 | 1/20 | 0.45 |
| ▸ | NEK2 | P51955 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4677574 | 0.86 | CYP3A4 (0.48) | KDM4ELMNAABL1CYP3A4RECQL | |
| SCHEMBL3436507 | 0.85 | KDM4E (0.51) | KDM4ELMNAABL1CYP3A4RECQL | |
| Hydrochloric Acid SCHEMBL5383897 | 0.84 | CYP3A4 (0.47) | KDM4ELMNAABL1CYP3A4RECQL | |
| SCHEMBL3435695 | 0.83 | CYP3A4 (0.52) | KDM4ELMNAABL1CYP3A4RECQL | |
| SCHEMBL3435131 | 0.83 | CYP3A4 (0.46) | KDM4ELMNAABL1CYP3A4RECQL | |
| SCHEMBL3543466 | 0.81 | LGMN (0.54) | KDM4ELMNARECQLALDH1A1TDP1 | |
| SCHEMBL3435672 | 0.78 | NEK2 (0.46) | KDM4ELMNAABL1CYP3A4RECQL | |
| SCHEMBL3549279 | 0.78 | KDM4E (0.49) | KDM4EABL1NEK2ALDH1A1TDP1 | |
| SCHEMBL3436043 | 0.77 | AKT2 (0.53) | KDM4ELMNAABL1CYP3A4RECQL | |
| SCHEMBL3434295 | 0.77 | CYP1A2 (0.44) | KDM4ELMNACYP3A4ALDH1A1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8163746-B2 | Azolecarboxamide derivative | ASTELLAS PHARMA INC. (JP) | 2012-04-24 | — | — | US | disclosed |
| US-20090286766-A1 | AZOLECARBOXAMIDE DERIVATIVE | ASTELLAS PHARMA INC. (JP) | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090286766-A1 | AZOLECARBOXAMIDE DERIVATIVE | GPR17, NTRK1, TRPV1 | KDM4E 1834/4885LMNA 4712/4885ABL1 174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.